- Home
- NWE vs XENE Comparison
NWE vs XENE Comparison
Compare NWE & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWE
- XENE
- Stock Information
- Founded
- NWE 1923
- XENE 1996
- Country
- NWE United States
- XENE Canada
- Employees
- NWE N/A
- XENE N/A
- Industry
- NWE Power Generation
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- NWE Utilities
- XENE Health Care
- Exchange
- NWE Nasdaq
- XENE Nasdaq
- Market Cap
- NWE 3.5B
- XENE 2.9B
- IPO Year
- NWE N/A
- XENE 2014
- Fundamental
- Price
- NWE $57.73
- XENE $39.61
- Analyst Decision
- NWE Hold
- XENE Strong Buy
- Analyst Count
- NWE 6
- XENE 11
- Target Price
- NWE $59.17
- XENE $52.73
- AVG Volume (30 Days)
- NWE 347.2K
- XENE 746.2K
- Earning Date
- NWE 10-27-2025
- XENE 11-11-2025
- Dividend Yield
- NWE 4.57%
- XENE N/A
- EPS Growth
- NWE 7.14
- XENE N/A
- EPS
- NWE 3.67
- XENE N/A
- Revenue
- NWE $1,527,970,000.00
- XENE $7,500,000.00
- Revenue This Year
- NWE $6.74
- XENE N/A
- Revenue Next Year
- NWE $5.07
- XENE $207.88
- P/E Ratio
- NWE $15.73
- XENE N/A
- Revenue Growth
- NWE 3.78
- XENE N/A
- 52 Week Low
- NWE $50.43
- XENE $26.74
- 52 Week High
- NWE $59.89
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- NWE 55.40
- XENE 61.59
- Support Level
- NWE $56.62
- XENE $38.23
- Resistance Level
- NWE $58.78
- XENE $40.52
- Average True Range (ATR)
- NWE 0.86
- XENE 1.32
- MACD
- NWE 0.02
- XENE 0.20
- Stochastic Oscillator
- NWE 67.99
- XENE 81.28
About NWE NorthWestern Energy Group Inc.
NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric utility operations, which include the generation, purchase, transmission, and distribution of electricity, and Natural Gas utility operations, which include the production, purchase, transmission, storage, and distribution of natural gas. The company uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric utility operations segment.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.